PNTG Stock Analysis: Buy, Sell, or Hold?
PNTG - The Pennant Group, Inc. Common Stock
$30.14
0.30 (1.01%)
▲
5d:
-3.92%
30d:
-10.59%
90d:
+3.75%
BUY
HIGH Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 05, 2026
Smart Money Accumulation
PNTG is down 3.9% this week, but smart money is accumulating calls. Top strike: $35 2026-05-15 with 733 OI. Call ratio: 100% View Scanner →
Strength: 6.9/10
Get Alerted When PNTG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PNTG appears deeply undervalued. Market expects -4.4% annual earnings decline despite 54% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: PNTG appears deeply undervalued. Market expects -4.4% annual earnings decline despite 54% recent earnings growth. Contrarian opportunity at discount to historical valuation.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$58.24
Based on 11.2% avg growth
INTRINSIC VALUE TODAY
$36.16
16.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PNTG is currently trading at $30.14, which is considered oversold relative to its 30-day fair value range of $31.20 to $33.82. From a valuation perspective, the stock is trading at a discount (Forward PE: 19.2) compared to its historical average (22.0). Remarkably, the market is currently pricing in an annual earnings decline of 4.4% over the next few years. This pessimistic expectation contrasts with the company's recent 53.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PNTG is in a strong uptrend. Immediate support is located at $29.07, while resistance sits at $34.16.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (27th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $37.83 (+25.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PNTG is in a strong uptrend. Immediate support is located at $29.07, while resistance sits at $34.16.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (27th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $37.83 (+25.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$31.20 -
$33.82
Company Quality Score
54/100
(HOLD)
Options IV Signal
27th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
83.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 27th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 25.5% below Wall St target ($37.83)
Fair Price Analysis
30-Day Fair Range
$31.20 -
$33.82
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$2.34
(7.7%)
Support & Resistance Levels
Support Level
$29.07
Resistance Level
$34.17
Current Trend
Strong Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.21
Wall Street Target
$37.83
(+25.5%)
Revenue Growth (YoY)
53.2%
Earnings Growth (YoY)
53.7%
Profit Margin
3.1%
Valuation Discount vs History
-4.4% cheaper
PE vs Historical
19.2 vs 22.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.4%
(market-implied from PE analysis)
1-Year Target
$28.81
(-4%)
2-Year Target
$27.55
(-9%)
3-Year Target
$26.33
(-13%)
3-Yr Target (if PE normalizes)
(PE: 19→22)
$30.15
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 18.3%)
$58.08
(+93%)
Base:
(SPY PE: 19.2, Growth: 18.3%)
$49.93
(+66%)
Bear:
(PE: 16.3, Growth: 18.3%)
$42.44
(+41%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (37x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 36.96 | Current EPS (TTM): $0.84
Bull Case
$63.78
(+103%)
Analyst growth 86.7%, PE expands to 40.7
Base Case
$57.98
(+85%)
Market implied 86.7%, PE stable at 37.0
Bear Case
$21.11
(-33%)
Severe decline -20.0%, PE contracts to 31.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.2 to 22.0
Stabilization Target:
$34.51
(+14.5%)
PE Expansion Potential:
+14.5%
Share & Embed Analysis
Last updated: March 30, 2026 5:57 PM ET
Data refreshes hourly during market hours. Next update: 6:57 PM
Data refreshes hourly during market hours. Next update: 6:57 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PNTG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$261 | 62 BUY |
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$543 | 64 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$143 | 56 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 48 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$140 | 54 HOLD |
